InvestorsHub Logo

dr_lowenstein

12/11/14 11:31 AM

#27978 RE: cameron12x #27977

hmm let's see, Merck and Amgen just started melanoma trial- two years to primary end point- yeah I understand the argument about data from the ONCS Trial in a few months. yep. got it!

https://clinicaltrials.gov/ct2/show/NCT02263508?term=talimogene&rank=4